Tsujino S, Shanske S, DiMauro S
H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Department of Neurology, Columbia-Presbyterian Medical Center, New York, NY 10032, USA.
Muscle Nerve Suppl. 1995;3:S45-9. doi: 10.1002/mus.880181411.
Phosphoglycerate kinase (PGK; EC 2.7.2.3) is a glycolytic enzyme encoded by a single gene on the X chromosome and ubiquitously expressed. Hereditary PGK deficiency can cause hemolytic anemia, central nervous system dysfunction, and/or myopathy characterized by exercise intolerance, cramps, and myoglobinuria. So far, 20 PGK variants with reduced PGK activity have been identified, 8 of them in patients with myopathy. Six missense mutations and one splice-junction mutation have been identified in 7 patients, 2 of whom had myopathy. However, the biochemical and molecular bases for clinical heterogeneity in PGK deficiency remain unknown.
磷酸甘油酸激酶(PGK;EC 2.7.2.3)是一种糖酵解酶,由X染色体上的单个基因编码,在全身广泛表达。遗传性PGK缺乏可导致溶血性贫血、中枢神经系统功能障碍和/或肌病,其特征为运动不耐受、痉挛和肌红蛋白尿。到目前为止,已鉴定出20种PGK活性降低的变体,其中8种存在于患有肌病的患者中。在7例患者中鉴定出6个错义突变和1个剪接连接突变,其中2例患有肌病。然而,PGK缺乏临床异质性的生化和分子基础仍然未知。